Back

Anticholinergic bronchodilator improves both pulmonary and cardiac functions in patients with heart failure with reduced ejection fraction complicated with chronic obstructive pulmonary disease.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Chronic heart failure (CHF) Pharmacologic therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Kazuo Komamura

Toyota Memorial Hospital, Toyota (Japan)

31 More presentations in this session

Presentation thumbnail
Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm
Doctor P. Kanagala (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Cardiac mast cells exist in all chambers of the failing human heart and may contribute to human heart failure
Doctor M. Sandstedt (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Early diagnosis of anthracycline induced cardiotoxicity in a swine model by serial multiparametric cardiac magnetic resonance.
Mr C. Galan (Madrid, ES)
Abstract
Presentation thumbnail
Cardiovascular outcome of breast cancer patients with concomitant radiotherapy and chemotherapy in Korea: 10-year multicenter cohort study
Assistant Professor D. Kim (Suwon, KR)
Abstract
Presentation thumbnail
Baseline left atrial volume as a potential predictor of trastuzumab related cardiotoxicity in her 2 positive breast cancer patients.
Doctor G. Dolci (Arzignano, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources